Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

CAS 19501-58-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 19501-58-7
Also known as: 19501-58-7, (4-methoxyphenyl)hydrazine hydrochloride, 4-methoxyphenylhydrazine hcl, 70672-74-1, Mfcd00012945, P-methoxyphenylhydrazine hydrochloride
Molecular Formula
C7H11ClN2O
Molecular Weight
174.63  g/mol
InChI Key
FQHCPFMTXFJZJS-UHFFFAOYSA-N

1 2D Structure

CAS 19501-58-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4-methoxyphenyl)hydrazine;hydrochloride
2.1.2 InChI
InChI=1S/C7H10N2O.ClH/c1-10-7-4-2-6(9-8)3-5-7;/h2-5,9H,8H2,1H3;1H
2.1.3 InChI Key
FQHCPFMTXFJZJS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=CC=C(C=C1)NN.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 19501-58-7

2. (4-methoxyphenyl)hydrazine Hydrochloride

3. 4-methoxyphenylhydrazine Hcl

4. 70672-74-1

5. Mfcd00012945

6. P-methoxyphenylhydrazine Hydrochloride

7. 4-methoxyphenylhydrazine.hcl

8. (4-methoxyphenyl)hydrazine;hydrochloride

9. 1-(4-methoxyphenyl)hydrazine Hydrochloride

10. P-anisylhydrazine Hydrochloride

11. Chembl4167262

12. Hydrazine, (4-methoxyphenyl)-, Hydrochloride

13. 4-anisylhydrazine Hydrochloride

14. Hydrazine, (4-methoxyphenyl)-, Monohydrochloride

15. 4-hydrazinoanisole Hydrochloride

16. Einecs 243-115-3

17. 4-methoxyphenyl Hydrazine Hcl

18. 4-methoxyphenyl Hydrazine.hcl

19. Schembl129453

20. P-methoxyphenylhyrazine Hcl Salt

21. Pentamethylbenzenesulfonylchloride

22. 4-methoxyphenyl Hydrazine . Hcl

23. Dtxsid80173160

24. Fqhcpfmtxfjzjs-uhfffaoysa-n

25. 4-methoxy-phenylhydrazine Hcl Salt

26. Nsc84699

27. P-methoxyphenylhydrazin Hydrochloride

28. Str00890

29. 4-methoxyphenylhyrazine Hydrochloride

30. 4-metoxyphenylhydrazine Hydrochloride

31. Bdbm50282576

32. Nsc 84699

33. Nsc-84699

34. P-methoxyphenylhydrazine-hydrochloride

35. 4-methoxy-phenylhydrazine Hydrochloride

36. 4-methoxyphenyl Hydrazine Hydrochloride

37. Akos005259823

38. P-methoxy Phenyl-hydrazinehydrochloride

39. P-methoxyphenyl Hydrazine Hydrochloride

40. Ab11940

41. Ac-2542

42. Cs-w007694

43. (p-methoxyphenyl)hydrazine Hydrochloride

44. 4-methoxy Phenyl Hydrazine Hydrochloride

45. 4-methoxy-phenyl-hydrazine Hydrochloride

46. P-methoxy Phenyl-hydrazine-hydrochloride

47. (4-methoxyphenyl)hydrazine Xhydrochloride

48. P-methoxyphenylhydrazine Monohydrochloride

49. (4-methoxyphenyl)-hydrazine Hydrochloride

50. Bp-10042

51. 1-(p-methoxyphenyl)hydrazine Hydrochloride

52. N-(4-methoxyphenyl)hydrazine Hydrochloride

53. (4-methoxyphenyl)hydrazine Monohydrochloride

54. [4-(methyloxy)phenyl]hydrazine Hydrochloride

55. 4-methoxyphenylhydrazine Hydrochloride, 98%

56. Am20060957

57. Ft-0618959

58. Ft-0647565

59. M0637

60. (4-methoxyphenyl)-hydrazine Hydrochloride Salt

61. En300-68997

62. 4-methoxyphenylhydrazine Hydrochloric Acid Salt

63. A21628

64. M-3548

65. [4-(methyloxy)phenyl]hydrazine Monohydrochloride

66. F0001-0697

2.3 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 174.63 g/mol
Molecular Formula C7H11ClN2O
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area47.3
Heavy Atom Count11
Formal Charge0
Complexity89.6
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
Flag China
Digital Content Digital Content
URL Supplier Web Content
545445-44-1
Apixaban
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
27143-07-3
Apixaban
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY